Phase 3 Readout~month

Phase 3 Topline: An Efficacy and Safety, Phase III, Multi-center, Double-Blind, Randomized Controlled Study Comparing

Drug
major
Indication
Major Depressive Disorder (MDD); Depression; Depression - Major Depressive Disorder

Other upcoming events for HELP

Phase 3 ReadoutPhase 3 Topline: A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Co
Phase 3 ReadoutPhase 3 Topline: A Phase III Long-Term Extension Trial With Optional Additional Doses of CYB003 to Assess the Safety

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: An Efficacy and Safety, Phase III, Multi-center, Double-Blind, Randomized Controlled Study Comparing — HELP Phase 3 Readout | BioSniper